Paradigm Founder and Managing Director, Paul Rennie, provides a Company overview and details exciting phase 2 clinical data produced by Paradigm as the Company prepares for the next stage of the phase 3 clinical program in knee osteoarthritis.
Paradigm Founder and Managing Director, Paul Rennie, provides a Company overview and details exciting phase 2 clinical data produced by Paradigm as the Company prepares for the next stage of the phase 3 clinical program in knee osteoarthritis.